v3.24.1.1.u2
Condensed Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash flows from operating activities:    
Net loss $ (1,076) $ (3,257)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation expense 423 361
Unrealized gain on change in fair value of common warrants classified as a liability (1,362)
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets (79) 233
Deferred offering costs (27) (246)
Accounts payable (206) 294
Accrued expenses 123 (91)
Net cash used in operating activities (2,204) (2,706)
Cash flows from investing activities:    
Proceeds from maturities of marketable securities 2,032
Net cash provided by investing activities 2,032
Cash flows from financing activities:    
Proceeds from private placement offering, net of offering costs 5,378
Proceeds from exercise of stock options 42 6
Net cash provided by financing activities 5,420 6
Net increase (decrease) in cash and cash equivalents 3,216 (668)
Beginning of period 1,173 4,391
End of period 4,389 3,723
Supplemental of non-cash financing activities:    
Fair value of common warrant classified as a liability $ 1,928

Source

PDF HTML 10-Q Filing
ZIP XLS XBRL